Celon Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CLN?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	5,757	0.0107%
Institutions	11,352,306	21.1%
General Public	12,470,906	23.2%
Private Companies	30,027,531	55.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 22 shareholders own 76.84% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
55.8%	Glatton Sp. z o.o.	30,027,531	zł719.2m	0%	no data
7.58%	Generali Powszechne Towarzystwo Emerytalne S A	4,083,585	zł97.8m	0%	0.35%
2.96%	Aegon Asset Management UK Plc	1,596,312	zł38.2m	0%	0.05%
2.14%	Allianz Asset Management GmbH	1,154,274	zł27.6m	0%	no data
1.99%	UNIQA Österreich Versicherungen AG, Asset Management Arm	1,072,114	zł25.7m	0%	0.21%
1.78%	Quercus TFI S.A.	958,680	zł23.0m	0%	2.27%
0.98%	Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A.	525,914	zł12.6m	393%	0.02%
0.92%	Powszechne Towarzystwo Emerytalne PZU SA	493,454	zł11.8m	0%	0.04%
0.69%	Pioneer Pekao Towarzystwo Funduszy Inwestycyjnych S.A	373,073	zł8.9m	0%	0.3%
0.44%	Goldman Sachs Asset Management, L.P.	239,255	zł5.7m	0%	no data
0.41%	PTE Bankowy, Asset Management Arm	222,085	zł5.3m	0%	0.06%
0.35%	Franklin Resources, Inc.	189,042	zł4.5m	0%	no data
0.18%	Dimensional Fund Advisors LP	97,424	zł2.3m	1.91%	no data
0.15%	Santander Towarzystwo Funduszy Inwestycyjnych S.A.	80,338	zł1.9m	0%	0.03%
0.14%	Union Investment TFI S.A	73,494	zł1.8m	0%	0.09%
0.12%	AgioFunds Towarzystwo Funduszy Inwestycyjnych S.A.	63,924	zł1.5m	0%	0.08%
0.12%	GAMMA PKO Towarzystwo Funduszy Inwestycyjnych SA	62,000	zł1.5m	0%	0.01%
0.068%	BNPP Asset Management Holding	36,639	zł877.5k	0%	no data
0.054%	Rockbridge TFI S.A.	29,345	zł702.8k	0%	0.13%
0.011%	Artur Wieczorek	5,757	zł137.9k	0%	no data
0.0013%	State Street Global Advisors, Inc.	719	zł17.3k	41.3%	no data
0.0012%	Towarzystwo Funduszy Inwestycyjnych PZU SA	635	zł15.2k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/17 04:33
End of Day Share Price	2025/02/14 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Celon Pharma S.A. is covered by 9 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Kamil Kliszcz	Biuro maklerskie mBanku
Beata Szparaga-Wasniewska	Biuro maklerskie mBanku
Vladimira Urbankova	Erste Group Bank AG